To confirm whether p17 leads to similar phenomena in A549 and HeLa cancer cells, Western blot assays were performed to analyze signal changes in cells transfected with the pCI-neo-p17 plasmid or co-transfected with the Tpr shRNA. Here, TPR is linked to cancer.